Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase 1/2 2Phase 3 1Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Lymphoid 2Sarcoma 1Other hematologic neoplasm 1

Conditions

Multiple Myeloma 444Neoplasms, Plasma Cell 77Recurrence 62Lymphoma 52Lymphoma, Non-Hodgkin 48Leukemia 43Hodgkin Disease 43Leukemia, Myeloid, Acute 42Myelodysplastic Syndromes 37Leukemia, Lymphocytic, Chronic, B-Cell 35Precursor Cell Lymphoblastic Leukemia-Lymphoma 34Lymphoma, Mantle-Cell 29Lymphoma, Large B-Cell, Diffuse 29Lymphoma, Follicular 27Hematologic Neoplasms 24Burkitt Lymphoma 24Immunoglobulin Light-chain Amyloidosis 22Myeloproliferative Disorders 21Lymphoma, B-Cell, Marginal Zone 21Waldenstrom Macroglobulinemia 18Lymphoma, Large-Cell, Immunoblastic 18Neoplasms 17Lymphoma, T-Cell, Cutaneous 16Lymphoma, Large-Cell, Anaplastic 14Leukemia, Myelomonocytic, Chronic 14Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14Sezary Syndrome 13Mycosis Fungoides 13Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 12Leukemia, Myeloid, Accelerated Phase 12

Interventions

ARQ531 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Vascular Diseases × Plasma cell × Clear all
NCT03162536 2025-09-08

ARQ 531-101

ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)

Phase 1/2 Active not recruiting
190 enrolled
LymphoidOther hematologic neoplasmPlasma cellSarcoma

Blood Protein Disorders, Cardiovascular Diseases, Hemorrhagic Disorders, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Leukemia, Lymphoid, Lymphatic Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Waldenstrom Macroglobulinemia, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Recurrence, Vascular Diseases, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Hematologic Neoplasms, Hemostatic Disorders, Lymphoma, Mantle-Cell, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating

NCT06644443 2024-10-16

BCMA-GPRC5D CAR-T Therapy in Relapsed or Refractory Multiple Myeloma

Shenzhen University General Hospital

Phase 1/2 Recruiting
10 enrolled
LymphoidPlasma cell

Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, Hemorrhagic Disorders, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Hemostatic Disorders, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡